Heparin modification of a biomimetic bone matrix for controlled release of VEGF. (Q44866799)

7 December 2017

Heparin modification of a biomimetic bone matrix for controlled release of VEGF. (English)

1 reference

7 December 2017

0 references

1 reference

7

1 reference

7 December 2017

4

Angela Rösen-Wolff

1 reference

7 December 2017

Sven Knaack

1

1 reference

7 December 2017

Anja Lode

2

1 reference

7 December 2017

Birgit Hoyer

3

1 reference

7 December 2017

Anastasia Gabrielyan

5

1 reference

7 December 2017

Ingo Roeder

6

1 reference

7 December 2017

15 November 2013

1 reference

Journal of Biomedical Materials Research Part A

7 December 2017

1 reference

7 December 2017

102

1 reference

7 December 2017

10

1 reference

7 December 2017

3500-3511

1 reference

Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?

7 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Tissue engineering for bone defect healing: an update on a multi-component approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Vascularization in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Vascularization in tissue engineering: angiogenesis versus inosculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Chemotaxis of human articular chondrocytes and mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Heparin and heparan sulfate: biosynthesis, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Binding and release of basic fibroblast growth factor from heparinized collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Cultivation of human bone marrow stromal cells on three-dimensional scaffolds of mineralized collagen: influence of seeding density on colonization, proliferation and osteogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Quantitative and qualitative analyses of proteoglycans in cartilage extracts by precipitation with 1,9-dimethylmethylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Systems for therapeutic angiogenesis in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

The interaction of collagen and acid mucopolysaccharides. A model for connective tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

A study of the interactions between monomeric tropocollagen and glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

The impact of heparin intercalation at specific binding sites in telopeptide-free collagen type I fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Immobilization of heparin: approaches and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Interaction of glucuronic acid and iduronic acid-rich glycosaminoglycans and their modified forms with hydroxyapatite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Mineralised collagen--an artificial, extracellular bone matrix--improves osteogenic differentiation of bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Heparin modification of calcium phosphate bone cements for VEGF functionalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Porous three-dimensional scaffolds made of mineralised collagen: Preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Biomimetically Mineralized Salmon Collagen Scaffolds for Application in Bone Tissue Engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

Calcium phosphate bone cements, functionalized with VEGF: Release kinetics and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35020

21 January 2018

Identifiers

DOI

10.1002/JBM.A.35020

1 reference

release_ydtmlxi7cfc2fm23gtwuj3c4uy

7 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ydtmlxi7cfc2fm23gtwuj3c4uy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference